Media coverage
53
Media coverage
Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet PR Newswire Date 23/03/23 URL https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-for-global-phase-3b-study-of-radicava-ors-edaravone-in-als-301779833.html Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet Street Insider Date 23/03/23 URL https://www.streetinsider.com/Press+Releases/Mitsubishi+Tanabe+Pharma+America+Announces+Enrollment+Completion+for+Global%2C+Phase+3b+Study+of+RADICAVA+ORS%C2%AE+%28edaravone%29+in+ALS/21409241.html Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet BioSpace Date 23/03/23 URL https://www.biospace.com/article/releases/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-for-global-phase-3b-study-of-radicava-ors-edaravone-in-als/?s=110 Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® Media name/outlet User Walls Date 23/03/23 URL https://www.userwalls.news/health/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-6330357/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet Yahoo! Finance Date 23/03/23 URL https://finance.yahoo.com/news/mitsubishi-tanabe-pharma-america-announces-130000349.html Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet Spoke.com Date 23/03/23 URL https://www.spoke.com/press_releases/641c4e5d04338f4118008931 Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet APNews.com Date 23/03/23 URL https://apnews.com/press-release/pr-newswire/health-jersey-city-medical-research-pr-newswire-57caacae581769663af6981c22887baa Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet TickerTech.com Date 23/03/23 URL www.tickertech.com/cgi/?a=news&ticker=a&w=&story=202303202303230900PR_NEWS_USPR_____NY50406 Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet AutoBlog.com Date 23/03/23 URL https://www.autoblog.com/press-releases/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-for-global-phase-3b-study-of-radicava-ors-edaravone-in-als_45175 Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WDTV Date 23/03/23 URL https://www.wdtv.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet KLTV 7 Country/Territory United States Date 23/03/23 URL www.kltv.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet KFVS12 Date 23/03/23 URL www.kfvs12.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet KWQC Country/Territory United States Date 23/03/23 URL https://www.kwqc.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WBKO Country/Territory United States Date 23/03/23 URL https://www.wbko.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet Fox 8 WVUE New Orleans Date 23/03/23 URL www.fox8live.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WALB 10 Country/Territory Georgia Date 23/03/23 URL www.walb.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet NBC 11 News Country/Territory United States Date 23/03/23 URL https://www.nbc11news.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet Kait 8 Country/Territory United States Date 23/03/23 URL www.kait8.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet Live 5 WCSC Date 23/03/23 URL www.live5news.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet KOLO TV Reno Country/Territory United States Date 23/03/23 URL https://www.kolotv.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet NBCNebraskaScottsbluff.com Country/Territory United States Date 23/03/23 URL https://www.nbcnebraskascottsbluff.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WWNY TV 7 Date 23/03/23 URL www.wwnytv.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet NBC12 Online Country/Territory United States Date 23/03/23 URL www.nbc12.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet NewsChannel 10 Country/Territory United States Date 23/03/23 URL www.newschannel10.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet KEYC Country/Territory United States Date 23/03/23 URL www.keyc.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet KCBD Country/Territory United States Date 23/03/23 URL www.kcbd.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet KSNB Local4 Country/Territory United States Date 23/03/23 URL https://www.ksnblocal4.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WCAX TV3 Country/Territory United States Date 23/03/23 URL https://www.wcax.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet Hawaii News Now Date 23/03/23 URL www.hawaiinewsnow.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet Wave 3 Country/Territory United States Date 23/03/23 URL www.wave3.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WECT TV-6 Date 23/03/23 URL www.wect.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WAFB Date 23/03/23 URL www.wafb.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet Upper Michigans Source Date 23/03/23 URL https://www.uppermichiganssource.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WHSV Country/Territory United States Date 23/03/23 URL https://www.whsv.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet 14 WFIE Country/Territory United States Date 23/03/23 URL www.14news.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet Fox 19 Country/Territory United States Date 23/03/23 URL www.fox19.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WCJB Country/Territory United States Date 23/03/23 URL https://www.wcjb.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WLBT Date 23/03/23 URL www.wlbt.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WDAM-TV Date 23/03/23 URL www.wdam.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WCTV6 Country/Territory United States Date 23/03/23 URL https://www.wctv.tv/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet KWTX Country/Territory United States Date 23/03/23 URL https://www.kwtx.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet KBTX.com Country/Territory United States Date 23/03/23 URL https://www.kbtx.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WBRC Country/Territory United States Date 23/03/23 URL https://www.wbrc.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WKYT Country/Territory United States Date 23/03/23 URL https://www.wkyt.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet NBC15 Country/Territory United States Date 23/03/23 URL https://www.nbc15.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet KCRG.com Country/Territory United States Date 23/03/23 URL https://www.kcrg.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WSAZ Date 23/03/23 URL https://www.wsaz.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WBAY Green Bay Country/Territory United States Date 23/03/23 URL https://www.wbay.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WSFA Country/Territory United States Date 23/03/23 URL https://www.wsfa.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet KKTV.com Country/Territory United States Date 23/03/23 URL https://www.kktv.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WLOX Date 23/03/23 URL https://www.wlox.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet KYTV Date 23/03/23 URL https://www.ky3.com/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo Title Mitsubishi Tanabe Pharma America Announces Enrollment Completion for Global, Phase 3b Study of RADICAVA ORS® (edaravone) in ALS Media name/outlet WVLT Country/Territory United States Date 23/03/23 URL https://www.wvlt.tv/prnewswire/2023/03/23/mitsubishi-tanabe-pharma-america-announces-enrollment-completion-global-phase-3b-study-radicava-ors-edaravone-als/ Persons Andrés Caicedo